Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


 Raj Bandaru

Raj Bandaru

Sanofi Pharmaceuticals, USA

Title: Integration of clinical study data to support trial simulation activities


Biography: Raj Bandaru


Like much of the pharmaceutical industries, we at Sanofi are also experiencing a shift in clinical development strategies to adopt more digital technologies and analytics placing greater emphasis on data and model driven approaches. We have set up a strong integrated capability across quantitative systems models, disease progression models and empirical models driving a rigorous clinical trial simulation process to inform design and key decisions in our clinical research. To this end, access to historical clinical trial data has been central. However, using clinical study data for broader clinical research use has several limitations and challenges. We are implementing several processes and intelligent informatics solutions to enable easier access to clinical study results and conducting integrated analytics using state of the art methods and tools. Here we describe some of the informatics solutions we are developing and how these could eventually be applied to support trial submission activities. One example is in the use of a machine learning methods to index data and make it searchable without compromising data security or patient privacy. We are also applying intelligent approaches to data de-identification and harmonization across multiple studies to support meta-analysis. A pilot effort using a learning based approach to data harmonization has shown significant promise and we are exploring other applications including management of metadata and terminologies using machine learning approaches. Some challenges however still exist primarily in the governance of data access and patient privacy issues. We are working on developing clear rules and guidelines that will eventually also help with automating data governance activities. Another challenging area will be in handling genomic and digital health data and we foresee an opportunity for automated machine learning algorithms to help in not only managing the data, but to also discover patterns and associations to clinical outcomes.